Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine

Cancer Research

Volumn 56, Issue 11, 1996, Pages 2479-2483

  Hu, Xueyou ^a   Chakraborty, Nitya G ^a   Sporn, Jonathan R ^a   Kurtzman, Scott H ^a   Ergin, M T ^a   Mukherji, Bijay ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A1 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELANOMA ANTIGEN; MELANOMA VACCINE; MESSENGER RNA; NONAPEPTIDE; RECOMBINANT INTERLEUKIN 2; SYNTHETIC PEPTIDE;

ACTIVE IMMUNIZATION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROLYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNIZATION; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; VACCINES;

EID: 0029927258     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Boon, T. Genetic analysis of tumor rejection antigens Adv Cancer Res., 58: 177-210, 1992
2. Houghton, A. N. Cancer antigens. immune recognition of self and altered self. J. Exp. Med., 180: 1-4, 1994
3. Van der Bruggen, P. Traversari, C , Chomez, P. Lurquin, C., De Plaen, E., Van den Eynde, B , Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
4. Brichard, V., Van Pel, A , Wolfel, T , Wolfel, C., De Plaen, E., Lethé, B., Coulie, P., and Boon, T The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J. Exp. Med , 178: 489-495, 1993.
5. Coulie, P., Brichard, V , Van Pel, A., Wolfel, T., Schneider, J , Traversari, C., Mattei, S , De Plaen, E , Lurquin, C., Szikora, J-P., Renauld, J-C , and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp. Med., 180: 35-52, 1994.
6. Kawakami, Y , Eliyahu, S , Sakaguchi, K , Robbins, P., Rivoltini, L., Yannelli, J , Apella, A., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLAA2-restricted tumor infiltrating lymphocytes. J Exp. Med., 180: 347-352, 1994.
7. Kawakami, Y , Eliyahu, S , Delgado, C , Robbins, P , Rivoltini, L., Topalian, S., Miki, T , and Rosenberg, S. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad Sci USA , 91: 3515-3519, 1994.
8. Kawakami, Y., Eliyahu, S., Delgado, C., Robbins, P., Sakaguchi, K., Appella, E , Yannelli, J., Adema, G., Miki, T., and Rosenberg, S. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad Sci. USA,91: 6458-6462, 1994.
9. Gaugler, B G , Van den Eynde, B , van der Bruggen, P., Romero, P., Gaforio, J J , De Plaen, E., Lethé, B , Brasseur, F., and Boon, T Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes J Exp. Med., 179 921-930, 1995.
10. ink4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269. 1281-1284, 1995.
11. Traversari, C., van der Bruggen, P. Leuscher, I. F., Lurquin, C., Chomez, P , van Pel, A., de Plaen, E., Amar-Costesec, A , and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytotoxic T lymphocytes directed against tumor antigen MZ2-E J Exp Med , 176. 1453-1457, 1992
12. Mukherji, B , Chakraborty, N. G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J. R., Kurtzman, S K., Ergin, M. T., Ozols, J , Meehan, J., and Mauri, F. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells Proc. Natl. Acad Sci. USA 92. 8078-8082, 1995
13. Yamasaki, S., Okino, T., Chakraborty, N. G., Adkisson, O. A., Sampieri, A., Padula, S. J., Mauri, F , and Mukherji, B Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating factor cultured macrophages from HLA-A1 melanoma patients. Cancer Immunol. Immunother., 40: 268-271, 1995.
14. Mukherji, B., Guha, A., Chakraborty, N. G., Sivanandham, S., Nashed, A , Sporn, J. R., and Ergin, M. T Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J. Exp. Med., 169: 1961-1976, 1989.
15. Lefkovits, I., and Waldmann, H. Limiting dilution analysis of the cells of immune system. I. The clonal basis of the immune response. Immunol. Today, 5. 265-268, 1984.
16. Young, J W , and Inaba, K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med., 183: 7-11, 1995.
17. Steinman, R. M The dendritic cell system and its role in immunogenicity. Annu. Rev Immunol., 9: 271-296, 1991.
18. Nanda, N. K., and Sercarz, E. E. Induction of anti-self-immunity to cure cancer. Cell, 82. 13-17, 1995.